Detection of circulating prostate cells by reverse transcriptase- polymerase chain reaction of human glandular kallikrein (hK2) and prostate- specific antigen (PSA) messages

Urology

Volumn 50, Issue 2, 1997, Pages 184-188

  Corey, Eva ^a   Arfman, Edward W ^b   Oswin, Matthew M ^b   Melchior, Sebastian W ^b   Tindall, Donald J ^b   Young, Charles Y F ^b   Ellis, William J ^b   Vessella, Robert L ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

KALLIKREIN; MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BLOOD; BONE MARROW; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL;

EID: 0030856527     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00262-8     Document Type: Article

References (15)

1. Wood DP Jr, Banks ER, Humphreys S, McRoberts JW, and Rangnekar VM: Identification of bone marrow micrometastases in patients with prostate cancer. Cancer 74: 2533-2540, 1994.
2. Melchior SW, Corey E, Ellis WJ, Ross AA, Layton TJ, Oswin MM, Lange PH, and Vessella RL: Early tumor cell dissemination in patients with clinically localized carcinoma of the prostate. Clin Cancer Res 3: 249-256, 1997.
3. Chung LW: The role of stromal-epithelial interaction in normal and malignant growth. Cancer Surv 23: 33-42, 1995.
4. Schiedlich LJ, Bennetts BH, and Morris BJ: Primary structure of human glandular kallikrein gene. DNA 6: 429-437, 1987.
5. Young CY, Andrews PE, Montgomery BT, and Tindall DJ: Tissue-specific and hormonal regulation of human prostate-specific glandular kallikrein. Biochemistry 31: 818-824, 1992.
6. Young CY, Seay T, Hogen K, Charlesworth MC, Roche PC, Klee GG, and Tindall DJ: Prostate-specific human kallikrein (hK2) as a novel marker for prostate cancer. Prostate 7(suppl): 17-24, 1996.
7. Hermanek P, and Sobin LH (Eds): UICC TNM Classification of Malignant Tumors, 4th ed. Berlin, Springer-Verlag, 1992.
8. Corey E, Arfman EW, Liu AY, and Vessella RL: Improved reverse transcriptase-polymerase chain reaction protocol with exogenous internal competitive control for prostate-specific antigen mRNA in blood and bone marrow. Clin Chem 43: 443-452, 1997.
9. Israeli RS, Miller WH Jr, Su SL, Powell T, Fair WR, Samadi DS, Huryk RF, De Blasio A, Edwards ET, Wise GJ, et al: Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res 54: 6306-6310, 1994.
10. Katz AE, Olsson CA, Raffo AJ, Cama C, Perlman H, Seaman E, O'Toole KM, McMahon D, Benson MC, and Buttyan R: Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology 43: 765-775, 1994.
11. Seiden MV, Kantoff PW, Krithivas K, Propert K, Bryant M, Halton E, Gaynes L, Kaplan I, Bubley G, DeWolf W, et al: Detection of circulating tumor cells in men with localized prostate cancer. J Clin Oncol 12: 2634-2639, 1994.
12. Ghossein RA, Scher HI, Gearld WL, Kelly WK, Amsterdam A, Zhang ZF, and Rosai J: Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma - clinical implications. J Clin Oncol 13: 1195-1200, 1995.
13. Katz AE, de Vries GM, Begg MD, Raffo AJ, Cama C, O'Toole K, Buttyan R, Benson MC, and Olsson CA: Enhanced reverse transcriptase polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer. Cancer 75: 1642-1648, 1995.
14. Sokoloff MH, Tso CL, Kaboo R, Nelson S, Ko J, Dorey F, Figlin RA, Pang S, de Kernion J, and Belldegrun A: Quantitative polymerase chain reaction (PCR) does not improve prostate cancer (PC) staging: clinicopathological molecular analysis of 121 patients. J Urol 155: 428A, 1996.
15. Ellis WJ, Vessella RL, Corey E, Arfman EW, Oswin M, Melchior SW, and Lange PH: Use of a reverse transcriptase polymerase chain reaction (RT-PCR) to detect prostate cells in the blood. J Urol 155: 272A, 1996.